{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T04:53:24Z","timestamp":1784436804612,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81530098"],"award-info":[{"award-number":["81530098"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573494"],"award-info":[{"award-number":["81573494"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573496"],"award-info":[{"award-number":["81573496"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["2015ZX09501001"],"award-info":[{"award-number":["2015ZX09501001"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20160076"],"award-info":[{"award-number":["BK20160076"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81421005"],"award-info":[{"award-number":["81421005"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ejps.2017.06.015","type":"journal-article","created":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T20:30:21Z","timestamp":1497385821000},"page":"313-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Glycyrrhetic acid, but not glycyrrhizic acid, strengthened entecavir activity by promoting its subcellular distribution in the liver via efflux inhibition"],"prefix":"10.1016","volume":"106","author":[{"given":"Qianying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowei","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2017.06.015_bb0005","doi-asserted-by":"crossref","first-page":"11994","DOI":"10.1128\/JVI.00653-10","article-title":"Apoptosis of hepatitis B virus-infected hepatocytes prevents release of infectious virus","volume":"84","author":"Arzberger","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.ejps.2017.06.015_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00430-014-0369-7","article-title":"Natural history of chronic hepatitis B virus infection","volume":"204","author":"Busch","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.ejps.2017.06.015_bb0015","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1021\/acs.molpharmaceut.5b00677","article-title":"Glycyrrhetinic acid mediated drug delivery carriers for hepatocellular carcinoma therapy","volume":"13","author":"Cai","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2017.06.015_bb0020","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.antiviral.2015.06.001","article-title":"Suppression of porcine reproductive and respiratory syndrome virus proliferation by glycyrrhizin","volume":"120","author":"Duan","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejps.2017.06.015_bb0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/03602532.2015.1029634","article-title":"Potential drug interactions associated with glycyrrhizin and glycyrrhetinic acid","volume":"47","author":"Feng","year":"2015","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejps.2017.06.015_bb0030","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/jac\/dkr388","article-title":"Nucleoside\/nucleotide analogues in the treatment of chronic hepatitis B","volume":"66","author":"Fung","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2017.06.015_bb0035","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4254\/wjh.v7.i2.150","article-title":"Gene therapeutic approaches to inhibit hepatitis B virus replication","volume":"7","author":"Gebbing","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.ejps.2017.06.015_bb0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.toxlet.2013.09.019","article-title":"Alpha-naphthylisothiocyanate modulates hepatobiliary transporters in sandwich-cultured rat hepatocytes","volume":"224","author":"Guo","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejps.2017.06.015_bb0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1043-6618(02)00121-4","article-title":"Hepatoprotective effects of 18beta-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: inhibition of cytochrome P450 2E1 expression","volume":"46","author":"Jeong","year":"2002","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejps.2017.06.015_bb0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jchromb.2012.12.011","article-title":"Simultaneous determination of gastrodin and puerarin in rat plasma by HPLC and the application to their interaction on pharmacokinetics","volume":"915-916","author":"Jiang","year":"2013","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ejps.2017.06.015_bb0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/toxsci\/kfu216","article-title":"Schisandrol B protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of liver regeneration","volume":"143","author":"Jiang","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejps.2017.06.015_bb0060","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3350\/cmh.2013.19.2.165","article-title":"Efficacy and safety of entecavir plus carnitine complex (GODEX\u00ae) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study","volume":"19","author":"Jun","year":"2013","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.ejps.2017.06.015_bb0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12906-016-0997-0","article-title":"Hepatoprotective effect of licorice, the root of glycyrrhiza uralensis Fischer, in alcohol-induced fatty liver disease","volume":"16","author":"Jung","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.ejps.2017.06.015_bb0070","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.3390\/v7092854","article-title":"Anti-HBV drugs: progress, unmet needs, and new hope","volume":"7","author":"Kang","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.ejps.2017.06.015_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2014.11.002","article-title":"The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade","volume":"18","author":"Kathawala","year":"2015","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ejps.2017.06.015_bb0080","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.2165\/11208510-000000000-00000","article-title":"Entecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease","volume":"71","author":"Keating","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.ejps.2017.06.015_bb0085","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.23346","article-title":"Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function","volume":"50","author":"Lange","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ejps.2017.06.015_bb0090","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/fcp.12126","article-title":"Sunitinib-ibuprofen drug interaction affects the pharmacokinetics and tissue distribution of sunitinib to brain, liver, and kidney in male and female mice differently","volume":"29","author":"Lau","year":"2015","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2017.06.015_bb0095","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","article-title":"Mechanisms of HBV-induced hepatocellular carcinoma","volume":"64","author":"Levrero","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejps.2017.06.015_bb0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3724\/SP.J.1009.2013.00309","article-title":"Effect of diammonium glycyrrhizinate on entecavir pharmacokinetics in rats","volume":"11","author":"Li","year":"2013","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.ejps.2017.06.015_bb0105","first-page":"872139","article-title":"Glycyrrhizic acid in the treatment of liver diseases: literature review","volume":"2014","author":"Li","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ejps.2017.06.015_bb0110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.taap.2013.12.015","article-title":"Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: herb-drug interactions mediated via P-gp","volume":"275","author":"Li","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejps.2017.06.015_bb0115","first-page":"883","article-title":"Entecavir versus lamivudine for the treatment of chronic hepatitis B: a systematic review","volume":"67","author":"Liang","year":"2012","journal-title":"Die Pharmazie"},{"key":"10.1016\/j.ejps.2017.06.015_bb0120","first-page":"304","article-title":"Entecavir interacts with influx transporters hOAT1, hCNT2, hCNT3, but not with hOCT2: the potential for renal transporter-mediated cytotoxicity and drug-drug interactions","volume":"6","author":"Mandikova","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2017.06.015_bb0125","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2893.2011.01579.x","article-title":"Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52weeks","volume":"19","author":"Manns","year":"2012","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.ejps.2017.06.015_bb0130","first-page":"635","article-title":"Ammonium glycyrrhizinate-loaded niosomes as a potential nanotherapeutic system for anti-inflammatory activity in murine models","volume":"9","author":"Marianecci","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejps.2017.06.015_bb0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/10428190109057970","article-title":"Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma","volume":"41","author":"Matsuo","year":"2001","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ejps.2017.06.015_bb0140","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.jbiomech.2012.05.027","article-title":"Temperature affects transport of polysaccharides and proteins in articular cartilage explants","volume":"45","author":"Moeini","year":"2012","journal-title":"J. Biomech."},{"key":"10.1016\/j.ejps.2017.06.015_bb0145","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00280-007-0676-4","article-title":"Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals","volume":"62","author":"Nabekura","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejps.2017.06.015_bb0150","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1021\/mp500394v","article-title":"Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy","volume":"12","author":"Qi","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2017.06.015_bb0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.coviro.2015.08.015","article-title":"Oncogenic potential of hepatitis B virus encoded proteins","volume":"14","author":"Ringelhan","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ejps.2017.06.015_bb0160","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","article-title":"Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA","volume":"84","author":"Sells","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2017.06.015_bb0165","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s12272-014-0375-8","article-title":"Effect of Sophora flavescens on the pharmacokinetics of carbamazepine in rats","volume":"37","author":"Shi","year":"2014","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejps.2017.06.015_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1386-6346(00)00123-6","article-title":"Treatment of subacute hepatitis with lamivudine and intravenous glycyrrhizin: a pilot study","volume":"20","author":"Tandon","year":"2001","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.ejps.2017.06.015_bb0175","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.3748\/wjg.v20.i20.6262","article-title":"Management of chronic hepatitis B infection: current treatment guidelines, challenges, and new developments","volume":"20","author":"Tang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejps.2017.06.015_bb0180","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4254\/wjh.v6.i3.144","article-title":"Hepatoprotective effect of silymarin","volume":"6","author":"Vargas-Mendoza","year":"2014","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.ejps.2017.06.015_bb0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.phymed.2008.12.018","article-title":"Synergy research: approaching a new generation of phytopharmaceuticals","volume":"16","author":"Wagner","year":"2009","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejps.2017.06.015_bb0190","first-page":"1465","article-title":"The combination of glycyrrhizin and lamivudine can reverse the cisplatin resistance in hepatocellular carcinoma cells through inhibition of multidrug resistance-associated proteins","volume":"31","author":"Wakamatsu","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejps.2017.06.015_bb0195","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2174\/1389450115666140309232100","article-title":"Recent advances in active hepatic targeting drug delivery system","volume":"15","author":"Wang","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejps.2017.06.015_bb0200","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/biof.1136","article-title":"ATP-binding cassette transporters in liver","volume":"40","author":"Wlcek","year":"2014","journal-title":"Biofactors"},{"key":"10.1016\/j.ejps.2017.06.015_bb0205","first-page":"47","article-title":"The efficacy of enticavir with compound glycyrrhizin for forty-eight liver cancer patients","volume":"51","author":"Xie","year":"2013","journal-title":"China Mod. Doct."},{"key":"10.1016\/j.ejps.2017.06.015_bb0210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/bdd.1789","article-title":"Effects of glycyrrhizin on biliary transport and hepatic levels of glutathione in rats","volume":"33","author":"Xu","year":"2012","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2017.06.015_bb0215","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ejps.2012.12.024","article-title":"OAT1 and OAT3: targets of drug-drug interaction between entecavir and JBP485","volume":"48","author":"Xu","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.06.015_bb0220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejps.2013.10.010","article-title":"The oligopeptide transporter 2-mediated reabsorption of entecavir in rat kidney","volume":"52","author":"Xu","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.06.015_bb0225","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejps.2015.02.010","article-title":"Decreased liver distribution of entecavir is related to down-regulation of Oat2\/Oct1 and up-regulation of Mrp1\/2\/3\/5 in rat liver fibrosis","volume":"71","author":"Xu","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.06.015_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2011.03.018","article-title":"Organic anion and cation transporters are possibly involved in renal excretion of entecavir in rats","volume":"89","author":"Yanxiao","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.ejps.2017.06.015_bb0235","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1124\/dmd.107.019513","article-title":"Inhibitory effects of terpenoids on multidrug resistance-associated protein 2- and breast cancer resistance protein-mediated transport","volume":"36","author":"Yoshida","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.06.015_bb0240","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2174\/1389200211209050577","article-title":"Absorption, disposition, and pharmacokinetics of saponins from Chinese medicinal herbs: what do we know and what do we need to know more?","volume":"13","author":"Yu","year":"2012","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ejps.2017.06.015_bb0245","first-page":"37","article-title":"Clinical research of ETV combined therapy with compound glycyrrhizin acid treatment for compensatory phase active hepatitis B with cirrhosis","volume":"5","author":"Zhang","year":"2013","journal-title":"Chin. J. Liv. Dis."},{"key":"10.1016\/j.ejps.2017.06.015_bb0250","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1476-5381.2011.01505.x","article-title":"Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7\/Adr cells","volume":"165","author":"Zhang","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2017.06.015_bb0255","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/03602532.2011.560607","article-title":"Toward a new age of cellular pharmacokinetics in drug discovery","volume":"43","author":"Zhou","year":"2011","journal-title":"Drug Metab. Rev."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717303494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717303494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T08:48:30Z","timestamp":1656924510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098717303494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":51,"alternative-id":["S0928098717303494"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2017.06.015","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycyrrhetic acid, but not glycyrrhizic acid, strengthened entecavir activity by promoting its subcellular distribution in the liver via efflux inhibition","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2017.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}